EX-10.7 9 b315770ex10_07.txt FORM OF SECOND AMENDMENT TO EXTEND FILING DATE Exhibit 10.07 SECOND AMENDMENT TO AGREEMENT SECOND AMENDMENT TO AGREEMENT(the "Amendment"), between ZymeTx, Inc. (the "Company") and the investors identified on the signature pages hereto (the "Investors"). WHEREAS, on October 13, 2000, the Company and the Investors entered into a certain Registration Rights Agreement (the "RRA"); and WHEREAS, on October 13, 2000, the Company issued to the Investors $2 million in aggregate principal amount of the Company's 5% Senior Convertible Debentures Due October 12, 2002 (the "Debentures"); and WHEREAS, on November 19, 2001, the Company and the Investors entered into an agreement (the "Agreement") not to enforce certain rights of redemption under the RRA and the Debentures, with effect as of August 21, 2001; WHEREAS, on December 17, 2001, the Company and the Investors agreed to amend Section 2.4 of the Agreement, to provide that the Company shall have until December 24 to prepare and file the registration statement provided for therein; and WHEREAS, the Company and the Investors now agree to further amend Section 2.4 of the Agreement, to provide that the Company shall have until December 28 to prepare and file the registration statement provided for therein. THEREFORE, in consideration of the premises and mutual agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby duly acknowledged, the Company and the Investors agree as follows: ARTICLE I Section 2.4 shall be replaced in its entirety by the following: Section 2.4 New Registration Statement. ZymeTx shall prepare and file by December 28, 2001 a registration statement covering an additional 6,581,582 shares of Common Stock underlying the Debentures and the New Warrants. Any failure of the Company to do so shall be deemed an Interfering Event for purposes of the RRA. After filing, the Company shall use its best efforts to have that registration statement declared effective by the Securities and Exchange Commission as soon as possible. IN WITNESS WHEREOF, this Agreement is hereby executed and delivered by the duly authorized officers of the parties signing below. ZYMETX, INC. By: /s/ Norman R. Proulx --------------------------------- Norman R. Proulx Chief Executive Officer Date: December 21, 2001 ------------------------------- PALLADIN OPPORTUNITY FUND, LLC. By: Palladin Asset Management, L.L.C. Managing Member By: /s/ Robert Chender --------------------------------- Robert Chender Managing Member Date: December 21, 2001 ------------------------------- HALIFAX FUND, L.P. By: The Palladin Group, L.P. Attorney-in-Fact By: Palladin Capital Management, LLC General Partner By: /s/ Robert Chender --------------------------------- Robert Chender Managing Member Date: December 21, 2001 -------------------------------